192 related articles for article (PubMed ID: 23077247)
1. Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice.
Ma C; Kapanadze T; Gamrekelashvili J; Manns MP; Korangy F; Greten TF
J Leukoc Biol; 2012 Dec; 92(6):1199-206. PubMed ID: 23077247
[TBL] [Abstract][Full Text] [Related]
2. Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage.
Eggert T; Medina-Echeverz J; Kapanadze T; Kruhlak MJ; Korangy F; Greten TF
PLoS One; 2014; 9(11):e112717. PubMed ID: 25401795
[TBL] [Abstract][Full Text] [Related]
3. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection.
Czuprynski CJ; Brown JF; Maroushek N; Wagner RD; Steinberg H
J Immunol; 1994 Feb; 152(4):1836-46. PubMed ID: 8120393
[TBL] [Abstract][Full Text] [Related]
4. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice.
Daley JM; Thomay AA; Connolly MD; Reichner JS; Albina JE
J Leukoc Biol; 2008 Jan; 83(1):64-70. PubMed ID: 17884993
[TBL] [Abstract][Full Text] [Related]
5. Systemic Agonistic Anti-CD40 Treatment of Tumor-Bearing Mice Modulates Hepatic Myeloid-Suppressive Cells and Causes Immune-Mediated Liver Damage.
Medina-Echeverz J; Ma C; Duffy AG; Eggert T; Hawk N; Kleiner DE; Korangy F; Greten TF
Cancer Immunol Res; 2015 May; 3(5):557-66. PubMed ID: 25637366
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection.
Heim CE; Vidlak D; Scherr TD; Kozel JA; Holzapfel M; Muirhead DE; Kielian T
J Immunol; 2014 Apr; 192(8):3778-92. PubMed ID: 24646737
[TBL] [Abstract][Full Text] [Related]
7. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells.
Hestdal K; Ruscetti FW; Ihle JN; Jacobsen SE; Dubois CM; Kopp WC; Longo DL; Keller JR
J Immunol; 1991 Jul; 147(1):22-8. PubMed ID: 1711076
[TBL] [Abstract][Full Text] [Related]
8. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
Li H; Han Y; Guo Q; Zhang M; Cao X
J Immunol; 2009 Jan; 182(1):240-9. PubMed ID: 19109155
[TBL] [Abstract][Full Text] [Related]
9. The protective role of myeloid-derived suppressor cells in concanavalin A-induced hepatic injury.
Diao W; Jin F; Wang B; Zhang CY; Chen J; Zen K; Li L
Protein Cell; 2014 Sep; 5(9):714-24. PubMed ID: 24981055
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in mice.
Cheng L; Wang J; Li X; Xing Q; Du P; Su L; Wang S
PLoS One; 2011 Mar; 6(3):e17631. PubMed ID: 21394214
[TBL] [Abstract][Full Text] [Related]
11. Premetastatic soil and prevention of breast cancer brain metastasis.
Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
[TBL] [Abstract][Full Text] [Related]
12. Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells.
Liu G; Bi Y; Wang R; Yang H; Zhang Y; Wang X; Liu H; Lu Y; Zhang Z; Chen W; Chu Y; Yang R
J Immunol; 2014 Apr; 192(7):3068-79. PubMed ID: 24567529
[TBL] [Abstract][Full Text] [Related]
13. Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells.
Ribechini E; Leenen PJ; Lutz MB
Eur J Immunol; 2009 Dec; 39(12):3538-51. PubMed ID: 19830733
[TBL] [Abstract][Full Text] [Related]
14. Anti-Gr-1 Antibody Provides Short-Term Depletion of MDSC in Lymphodepleted Mice with Active-Specific Melanoma Therapy.
Rose P; van den Engel NK; Kovács JR; Hatz RA; Boon L; Winter H
Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455309
[TBL] [Abstract][Full Text] [Related]
15. Treatment with the antigranulocyte monoclonal antibody RB6-8C5 impairs resistance of mice to gastrointestinal infection with Listeria monocytogenes.
Czuprynski CJ; Theisen C; Brown JF
Infect Immun; 1996 Sep; 64(9):3946-9. PubMed ID: 8751957
[TBL] [Abstract][Full Text] [Related]
16. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
[TBL] [Abstract][Full Text] [Related]
17. Ly6C+ Ly6G- Myeloid-derived suppressor cells play a critical role in the resolution of acute inflammation and the subsequent tissue repair process after spinal cord injury.
Saiwai H; Kumamaru H; Ohkawa Y; Kubota K; Kobayakawa K; Yamada H; Yokomizo T; Iwamoto Y; Okada S
J Neurochem; 2013 Apr; 125(1):74-88. PubMed ID: 23278273
[TBL] [Abstract][Full Text] [Related]
18. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells in the development of lung cancer.
Ortiz ML; Lu L; Ramachandran I; Gabrilovich DI
Cancer Immunol Res; 2014 Jan; 2(1):50-8. PubMed ID: 24778162
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M
J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
